Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen®-Reference-Cited by-同舟云学术

Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen®

Published:2014-02-21 Issue:1 Volume:15 Page:
ISSN:2050-6511
Container-title:BMC Pharmacology and Toxicology
language:en
Short-container-title:BMC Pharmacol Toxicol

Author:

Crobu Davide,Spinetti Gaia,Schrepfer Rodolfo,Tonon Giancarlo,Jotti Gloria Saccani,Onali Pierluigi,Dedoni Simona,Orsini Gaetano,Di Stefano Andrea

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/article/10.1186/2050-6511-15-7/fulltext.html

Reference25 articles.

1. Frampton JE, Lee CR, Faulds D: Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs. 1994, 48: 731-760. 10.2165/00003495-199448050-00007.

2. Garcıa-Carbonero R, Mayordomo JI, Tornamira MV, Lopez-Brea M, Rueda A, Guillem V, Arcediano A, Yubero Ribera AF, Gomez C, Tres A, Perez-Gracia JL, Lumbreras C, Hornedo J, Cortes-Funes H, Paz-Ares L: Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial. J Natl Cancer Inst. 2001, 93: 31-38. 10.1093/jnci/93.1.31.

3. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 89. 1997, 7: 2233-2258.

4. Mackie AR, Losordo DW: CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. Tex Heart Inst J. 2011, 38 (5): 474-485.

5. Hollingshead LM, Goa KL: Recombinant granulocyte colony-stimulating factor. A review of its pharmacological properties and prospective role in neutropenic conditions, Drugs. 1991, 42: 300-330.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Systemic Administration of Granulocyte-Colony Stimulating Factor on Rate of Fracture Healing of Bone Defect in Goats as Animal Model;JULY ISSUE;2022-07-01

2. Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms;Frontiers in Bioengineering and Biotechnology;2022-02-09

3. Chondroitin Sulfate and Fucosylated Chondroitin Sulfate as Stimulators of Hematopoiesis in Cyclophosphamide-Induced Mice;Pharmaceuticals;2021-10-24

4. Effect of Filgrastim on adult male rats’ fertility and reproductive performance;Saudi Journal of Biological Sciences;2021-04

5. Reporting of quality attributes in scientific publications presenting biosimilarity assessments of (intended) biosimilars: a systematic literature review;European Journal of Pharmaceutical Sciences;2020-11